NALOXONE HYDROCHLORIDE (AUTOINJECTOR) Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Naloxone Hydrochloride (autoinjector), and when can generic versions of Naloxone Hydrochloride (autoinjector) launch?
Naloxone Hydrochloride (autoinjector) is a drug marketed by Kaleo Inc and is included in one NDA. There are eighteen patents protecting this drug.
This drug has one hundred and forty-one patent family members in fifteen countries.
The generic ingredient in NALOXONE HYDROCHLORIDE (AUTOINJECTOR) is naloxone hydrochloride. There are twelve drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Naloxone Hydrochloride (autoinjector)
A generic version of NALOXONE HYDROCHLORIDE (AUTOINJECTOR) was approved as naloxone hydrochloride by HOSPIRA on September 24th, 1986.
Summary for NALOXONE HYDROCHLORIDE (AUTOINJECTOR)
International Patents: | 141 |
US Patents: | 18 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 2 |
Formulation / Manufacturing: | see details |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for NALOXONE HYDROCHLORIDE (AUTOINJECTOR) |
DailyMed Link: | NALOXONE HYDROCHLORIDE (AUTOINJECTOR) at DailyMed |
Recent Clinical Trials for NALOXONE HYDROCHLORIDE (AUTOINJECTOR)
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Pfizer | Phase 1 |
National Institute on Drug Abuse (NIDA) | Phase 1 |
See all NALOXONE HYDROCHLORIDE (AUTOINJECTOR) clinical trials
Pharmacology for NALOXONE HYDROCHLORIDE (AUTOINJECTOR)
Drug Class | Opioid Antagonist |
Mechanism of Action | Opioid Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for NALOXONE HYDROCHLORIDE (AUTOINJECTOR)
US Patents and Regulatory Information for NALOXONE HYDROCHLORIDE (AUTOINJECTOR)
NALOXONE HYDROCHLORIDE (AUTOINJECTOR) is protected by eighteen US patents.
Patents protecting NALOXONE HYDROCHLORIDE (AUTOINJECTOR)
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: USE OF A DELIVERY DEVICE TO DELIVER A DOSE OF NALOXONE
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: USE OF A DELIVERY DEVICE TO ADMINISTER A DOSE OF NALOXONE
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems, and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: USE OF A DELIVERY DEVICE TO ADMINISTER A DOSE OF NALOXONE
Devices, systems and methods for medicament delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
International Patents for NALOXONE HYDROCHLORIDE (AUTOINJECTOR)
See the table below for patents covering NALOXONE HYDROCHLORIDE (AUTOINJECTOR) around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 2014012214 | DEVICE, SYSTEM AND METHOD FOR MEDICAMENT DELIVERY | ⤷ Try a Trial |
Australia | 2012211307 | Medicament delivery devices for administration of a medicament within a prefilled syringe | ⤷ Try a Trial |
Australia | 2006210865 | Devices, systems, and methods for medicament delivery | ⤷ Try a Trial |
Japan | 4948422 | ⤷ Try a Trial | |
Canada | 2791286 | DISPOSITIFS, SYSTEMES ET PROCEDES D'ADMINISTRATION DE MEDICAMENTS (DEVICES, SYSTEMS, AND METHODS FOR MEDICAMENT DELIVERY) | ⤷ Try a Trial |
United Kingdom | 2456245 | An auto-injector with recorded speech output | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for NALOXONE HYDROCHLORIDE (AUTOINJECTOR)
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1685839 | 92292 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |